Analysts Say This Small-Cap Biopharmaceutical Stock Is A Buy
The small-cap biopharmaceutical stock featured in today’s article is a Buy according to the consensus among analysts, who see upside potential of nearly 200% from current levels.
Trades
How To Play This Biotech Stock Headed For A Breakout (Or Breakdown)
A rectangle pattern has formed for the biotech stock featured in today’s article, and the author advises that “When this pattern is broken, a breakout or breakdown is expected.”
3 Newly Listed Biotech Stocks – And A Look At Their Market Debuts
Three biotech companies developing therapies for the treatment of cancer and other diseases – including infectious diseases like COVID-19 – began trading on Friday.